Will a 5-ASA a Day Keep the Cancer (and Dysplasia) Away?

Abstract

Prevention strategies for colorectal cancer in chronic ulcerative colitis (UC) are currently based on the identification of neoplasia by surveillance colonoscopy, but there is a great interest in the possibility of primary chemoprevention. 5-aminosalicylic acid (5-ASA) therapy is an attractive option for chemoprevention in UC due to the fact that it is a… (More)
DOI: 10.1111/j.1572-0241.2005.50218.x

Topics

  • Presentations referencing similar topics